Prothena Corp Public (PRTA) Operating Leases (2019 - 2026)
Prothena Corp Public (PRTA) posted quarterly Operating Leases of $4.8 million for Q1 2026, down 53.34% year-over-year from $10.2 million in Q1 2025, and down 13.23% quarter-over-quarter from $5.5 million in Q4 2025.
Analysis
Prothena Corp Public (PRTA) Operating Leases (2019 - 2026) Analysis & Trends
Prothena Corp Public's Operating Leases history runs 8 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- In Q1 2026, Operating Leases fell 53.34% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (down 53.34% YoY), while the FY2025 annual figure was $5.5 million, down 33.35% from the prior year.
- Operating Leases for Q1 2026 stood at $4.8 million, down from $5.5 million in the prior quarter.
- The five-year high for Operating Leases was $12.5 million in Q1 2024, with the low at $3.4 million in Q2 2023.
- The 5-year median for Operating Leases is $9.3 million (2024), against an average of $8.6 million.
- The sharpest annual moves came in 2023 and 2024: Operating Leases slumped 64.0% in 2023, then surged 176.62% in 2024.
- Prothena Corp Public's Operating Leases stood at $8.0 million in 2022, then jumped by 33.45% to $10.7 million in 2023, then decreased by 23.21% to $8.2 million in 2024, then tumbled by 33.35% to $5.5 million in 2025, then decreased by 13.23% to $4.8 million in 2026.
- Business Quant data shows PRTA's Operating Leases at $4.8 million in Q1 2026, $5.5 million in Q4 2025, and $9.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Prothena Corp Public | 510.50 Mn | 222.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.99 Mn |
| Mar 31, 2026 | 7.65 Mn |
| Dec 31, 2025 | 5.49 Mn |
| Sep 30, 2025 | 9.08 Mn |
| Jun 30, 2025 | 9.78 Mn |
| Mar 31, 2025 | 10.20 Mn |
| Dec 31, 2024 | 8.23 Mn |
| Sep 30, 2024 | 11.49 Mn |
| Jun 30, 2024 | 12.12 Mn |
| Mar 31, 2024 | 12.50 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Sep 30, 2023 | 10.74 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 4.89 Mn |
| Sep 30, 2022 | 8.03 Mn |
| Jun 30, 2022 | 9.58 Mn |
| Mar 31, 2022 | 10.88 Mn |
| Dec 31, 2021 | 6.39 Mn |
| Sep 30, 2021 | 13.75 Mn |
| Jun 30, 2021 | 15.15 Mn |